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Abstract
We retrospectively studied the expression of Yes-associated protein (YAP) using immunohistochemical staining in 10 cases of
head and neck squamous cell carcinoma with associated perineural invasion. We find that fibroblasts in areas associated with
perineural invasion show higher levels of nuclear YAP compared to fibroblasts in the stroma of normal mucosa, with a median cell
count of 35.4 per high-power field in the former and 3.9 in the latter. No differences were observed between the expression of
YAP phosphorylated at Ser127 in the tumoral stroma compared to that in the normal mucosa, with a median cell count
expression of 4.9 in the former versus 5.0 in the latter. Therefore, a strong and increased nuclear YAP expression in fibroblasts
associated with perineural invasion in head and neck squamous cell carcinoma suggests that YAP-mediated transcription programs
in these fibroblasts may contribute to perineural invasion.
Keywords
fibroblast, perineural invasion, squamous cell carcinoma, YAP expression
Received July 09, 2015. Received revised October 05, 2015. Accepted for publication October 21, 2015.
Introduction
The tumor microenvironment plays an important role in the
growth and invasive properties of tumors,1 recently reviewed
factors contributing to squamous cell carcinoma invasion in the
head and neck including cancer-associated fibroblasts (CAFs).
Fibroblasts within a tumor, CAFs, are an important component
of the tumor stroma, contributing to both the extracellular
matrix (ECM) and the release of growth factors that promote
tumor growth and invasion.2-6 YAP is a transcriptional coacti-
vator known to partner with Transcriptional enhancer associate
domain (TEAD) and other transcription factors to regulate gene
expression. In response to Hippo signaling, YAP is phosphory-
lated at Ser127 (pYAP) and retained in the cytoplasm by 14-3-
3–dependent cytoplasmic sequestration, preventing the activa-
tion of YAP-mediated transcription programs that regulate cell
proliferation, cell death, and cell fate decisions.6,9 Addition-
ally, ECM rigidity, cell tension, and changes in cell geometry
activate a YAP-dependent mechanoresponse independent of
Hippo signaling.7,8
Previous studies have shown elevated YAP expression in
tumor cells, for example, YAP is strongly expressed in tumor
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cell islands in basal cell carcinoma,9,10 but YAP is also
expressed in fibroblasts, such as peripheral nerve fibroblasts,11
and YAP has been implicated in lung fibroblast activation and
fibrosis.12 Both total and nuclear YAP (nYAP)-increased
expression are associated with poor patient survival in numer-
ous cancers, suggesting that YAP expression may have prog-
nostic value.8 Recent evidence from fibroblasts within mouse
mammary tumors at different stages of progression that show
increased nYAP suggests that YAP may have a tumor-
promoting role in fibroblasts within a tumor, in addition to its
more established role in epithelial cells.13
In the present study, we investigated the expression of YAP
and pYAP in fibroblasts at the sites of perineural invasion in
head and neck squamous cell carcinoma compared to fibro-
blasts in the stroma of normal mucosa and previous biopsy
sites. We find that fibroblasts in areas associated with peri-
neural invasion show higher levels of nYAP compared to fibro-
blasts in the stroma of normal mucosa, suggesting that YAP-
mediated transcription programs in these fibroblasts may con-
tribute to perineural invasion.
Materials and Methods
Tissue Samples
For this initial case series study, we selected 10 cases of head and
neck squamous cell carcinoma with perineural invasion from our
head and neck cancer database of over 500 cases. The patients
were mostly elderly males with a mean age of 71.1 years and a
male to female ratio of 9 to 1. Paraffin blocks were retrieved
from the files of the Department of Pathology at Montefiore
Medical Center, Albert Einstein College of Medicine, Bronx,
New York. The Institutional Review Board of Montefiore Med-
ical Center, Bronx, New York, granted us the permission to use
clinical information and tissue samples for research purposes.
All tissues were routinely fixed in 10% buffered formalin
and embedded in paraffin. The YAP (catalog number 4912)
and phospho-YAP (Ser127 catalog number 4911) antibodies
are from Cell Signaling, (Danvers, MA), whereas the secondary
antibody Dako Envisionþ system–horseradish peroxidase-
labeled polymer and anti-rabbit and chromogen 3,3’-diamino-
benzidine (DAB) substrate kit are from Dako Co. (Carpinteria,
CA). The expressions of YAP and pYAP were assessed in
stroma from areas of previous biopsy site reaction and tumoral
stroma.
Immunohistochemical Stain
The paraffin sections were cut at 5 mm thickness and were
placed on positively charged slides. Slides were placed in a
60C oven for an hour and then deparaffinized and rehydrated
through a series of xylene and graded alcohols. Endogenous
peroxidase was quenched in 3% H2O2 for 10 minutes. Antigen
retrieval was performed by placing the slides in an Oster (Boca
Raton, FL) vegetable steamer with Cell Marque (Rockline, CA)
Trilogy solution for YAP and Dako Target Retrieval Solution
for phospho-YAP (Ser127). The staining procedure was per-
formed in an automatic slide stainer (Dako Autostainer Plus).
The primary rabbit polyclonal antibodies, YAP and phospho-
YAP (Ser127), were applied in a dilution of 1:50 for 30 minutes
at room temperature followed by a secondary antibody for 30
minutes and DAB substrate as chromogen for 10 minutes.
Slides were counterstained with Surgipath (Buffalo Grove,
IL) hematoxylin, dehydrated through graded alcohols, cleared
in xylene, and coverslipped with Cytoseal 60 from Richard-
Allan Scientific (Waltham, MA).
The staining patterns were classified as cytoplasmic or
nuclear, and the staining intensity was divided into 4 cate-
gories—0: no staining, 1þ: weakly stained, 2þ: moderately
stained, and 3þ: strongly stained. Only cells staining as 2þ
or 3þ were considered positive. The number of positive fibro-
blasts at each site, normal stroma and tumoral stroma, was
determined by counting the total number of positive cells in
5 high-power fields (HPFs) and calculating the average number
of cells per HPF. The median for the average counts at each site
for YAP and pYAP is presented in Table 1. Two pathologists
performed the assessment of YAP and pYAP expression in the
benign and tumoral stroma. There was good concordance
between the pathologists, and the results from 1 pathologist are
reported in Table 1.
Results
Since YAP has been suggested as a prognostic marker in
numerous cancers, YAP expression was examined with a par-
ticular focus on CAFs in the tumoral stroma and areas associ-
ated with perineural invasion using both an antibody that
detects total YAP protein as well as an antibody that specifi-
cally detects pYAP.
Analysis of the 10 cases demonstrated CAFs at sites of
perineural invasion and in cancer stroma had a higher number
of fibroblasts displaying strong nYAP expression compared to
Table 1. YAP and pYAP-Positive Fibroblasts in Tumoral Stroma Ver-
sus Benign Stroma*.
Case
YAP (Positive Cells/HPF) p-YAP (Positive Cells/HPF)
Benign
Stroma
Tumoral
Stroma
Benign
Stroma
Tumoral
Stroma
1 6.8 11.2 5.3 17.0
2 8.6 42 4.0 5.0
3 0.6 69.4 9.6 6.0
4 2.8 45.1 5.4 4.6
5 1.2 46.0 4.6 4.8
6 5.5 37.2 2.8 1.1
7 0.4 33.6 2.6 4.4
8 0 8.0 0 2.0
9 5.0 22.6 9.0 10.4
10 6.4 22.0 14.6 6.6
Median 3.9 35.4 5.0 4.9
Abbreviations: HPF, high-power field; pYAP, phosphorylated at Ser127.
*See Methods.
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fibroblasts in areas of benign mucosa. Overall, the median
fibroblast count with nYAP expression was 35.4 cells/HPF in
the tumoral stroma, which was nearly 10 times higher than that
found in the benign stroma (3.9 cells/HPF; Table 1). Some
pYAP staining was also observed in the CAFs at sites of peri-
neural invasion and cancer stroma, but the levels were lower
than that of nYAP. In benign squamous stroma associated with
previous biopsy site reaction, there were low levels of fibro-
blasts with YAP and pYAP staining.
Overall, the expression level of YAP was higher in both
CAFs and tumor cells, especially the nYAP. The pYAP was
also seen in both CAFs and tumor cells, but mainly in the
cytoplasmic location. The expression of YAP and pYAP in
CAFs at sites of perineural invasion as well as fibroblasts in
the tumoral stroma and benign mucosal stroma are shown (Fig-
ures 1 and 2).
Discussion
We studied the expression of YAP and pYAP in the tumoral
stroma of CAF, CAF associated with perineural invasion, and
fibroblasts at normal squamous mucosa and previous biopsy
sites. We found that CAF and CAF with perineural invasion
had a high YAP expression. It has already been demonstrated
that tumors, especially malignant ones that contain a complex
ECM due to desmoplastic reactions to the tumor cells, increase
stiffness of the ECM, which further enhances tumor invasion
and metastasis. The Hippo pathway regulates organ size and
tumorigenesis in Drosophila and mammals and is altered in a
variety of human cancers.11,14 In a study of the Hippo pathway
in ovarian cancer by Hall and colleagues, the authors found that
the effective YAP, specifically high levels of nYAP or low
levels of cytoplasmic phosphorylated YAP (cpYAP), was asso-
ciated with poor survival in patients with ovarian cancer. Con-
sistent with these findings, Steinhardt and colleagues found that
nuclear and cytoplasmic YAP protein expression was signifi-
cantly higher in carcinoma cells of the colon, lungs, and ovaries
than in their counterpart benign components, indicating active
proliferation.15 The study by Yeo and colleagues has reported
that YAP and pYAP protein expression was increased in breast
borderline/malignant phyllodes tumor compared to in benign
phyllodes tumor16 and found that higher nuclear expression of
YAP was associated with worse overall and disease-free sur-
vival in patients with esophageal squamous cell carcinoma in a
Korean population.16 Most studies investigated YAP protein
expression in malignant epithelial or stromal cells. In the study
by Calvo et al, the ability of CAFs to promote cancer cell
invasion was also significantly dependent on YAP function,
whereas Transcriptional co-activator with PDZ-binding motif
(TAZ) was not required.17 The authors also showed that deple-
tion of YAP reduced the ability of CAFs to form fibrous col-
lagen networks and promote angiogenesis in vivo, whereas
transforming growth factor b (TGF-b) promoted nuclear accu-
mulation of YAP.13
Figure 1. A, Benign squamous cell mucosa, hematoxylin and eosin
(H&E) section, 200. B, Immunostain of YAP, no to rare basal cells
and fibroblasts with nuclear and cytoplasmic expression, 200. C,
Immunostain of phosphorylated at Ser127 (pYAP), scattered basal
cells and fibroblasts with nuclear and cytoplasmic expression,
200.
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In our study, we found that high level of nYAP in CAFs is
associated with perineural invasion, with fibroblasts that have a
low level of cpYAP expression indicating a more aggressive
pattern of invasion. They also had more extensive desmoplastic
stroma composed of inflammatory cells, which might produce
some chemokines, cytokines, and TGF-b,18 which could be
involved in accumulating nYAP in the CAFs. In benign
mucosa, no to few fibroblasts are present, and they usually have
weak nYAP expression and seem less activated. Our observa-
tion was consistent with the finding by others that YAP with a
nuclear location was critical for CAFs to produce a rigid col-
lagen network that stimulates and promotes tumor invasion into
peripheral nerves.
In conclusion, strong nYAP staining in perineural invasion
associated with stromal fibroblasts in head and neck squamous
cell carcinoma suggests that YAP-mediated transcription pro-
grams may contribute to perineural invasion.
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